cabazitaxel

Open Access
Risk Factors and Clinical Significance of Grade ≥3 Neutropenia During the First Cycle of Cabazitaxel Therapy With Primary Pegfilgrastim Prophylaxis in Metastatic Castration-resistant Prostate Cancer
RYO SATO, YUKIHIRO YOSHIMI, TETSUHARU NISHIO, YU MATSUNAGA and RIKIYA MATSUMOTO

In Vivo May 2026, 40 (3) 1628-1636; DOI: https://doi.org/10.21873/invivo.14313
You have access
Sarcopenia and Visceral Metastasis at Cabazitaxel Initiation Predict Prognosis in Patients With Castration-resistant Prostate Cancer Receiving Cabazitaxel Chemotherapy
HIROAKI IWAMOTO, HIROSHI KANO, TAKAFUMI SHIMADA, RENATO NAITO, TOMOYUKI MAKINO, SUGURU KADOMOTO, HIROSHI YAEGASHI, KAZUYOSHI SHIGEHARA, KOUJI IZUMI, YOSHIFUMI KADONO and ATSUSHI MIZOKAMI

In Vivo May 2021, 35 (3) 1703-1709; DOI: https://doi.org/10.21873/invivo.12430

Main menu